IBDEI20L ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33754,0)
 ;;=J0886^^153^1699^6^^^^1
 ;;^UTILITY(U,$J,358.3,33754,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33754,1,2,0)
 ;;=2^Epoetin Alfa,ESRD Use,1000 Units
 ;;^UTILITY(U,$J,358.3,33754,1,3,0)
 ;;=3^J0886
 ;;^UTILITY(U,$J,358.3,33755,0)
 ;;=J1642^^153^1699^11^^^^1
 ;;^UTILITY(U,$J,358.3,33755,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33755,1,2,0)
 ;;=2^Heparin Sodium per 10 Units
 ;;^UTILITY(U,$J,358.3,33755,1,3,0)
 ;;=3^J1642
 ;;^UTILITY(U,$J,358.3,33756,0)
 ;;=92950^^153^1700^5^^^^1
 ;;^UTILITY(U,$J,358.3,33756,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33756,1,2,0)
 ;;=2^Heart/Lung Resuscitation CPR
 ;;^UTILITY(U,$J,358.3,33756,1,3,0)
 ;;=3^92950
 ;;^UTILITY(U,$J,358.3,33757,0)
 ;;=93224^^153^1700^3^^^^1
 ;;^UTILITY(U,$J,358.3,33757,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33757,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Intrp & Rpt
 ;;^UTILITY(U,$J,358.3,33757,1,3,0)
 ;;=3^93224
 ;;^UTILITY(U,$J,358.3,33758,0)
 ;;=93225^^153^1700^4^^^^1
 ;;^UTILITY(U,$J,358.3,33758,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33758,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Recording Only
 ;;^UTILITY(U,$J,358.3,33758,1,3,0)
 ;;=3^93225
 ;;^UTILITY(U,$J,358.3,33759,0)
 ;;=93226^^153^1700^1^^^^1
 ;;^UTILITY(U,$J,358.3,33759,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33759,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Analysis & Rpt
 ;;^UTILITY(U,$J,358.3,33759,1,3,0)
 ;;=3^93226
 ;;^UTILITY(U,$J,358.3,33760,0)
 ;;=93227^^153^1700^2^^^^1
 ;;^UTILITY(U,$J,358.3,33760,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33760,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Intrp
 ;;^UTILITY(U,$J,358.3,33760,1,3,0)
 ;;=3^93227
 ;;^UTILITY(U,$J,358.3,33761,0)
 ;;=36245^^153^1701^1^^^^1
 ;;^UTILITY(U,$J,358.3,33761,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33761,1,2,0)
 ;;=2^Ins Cath Abd/L-Ext Art,1st
 ;;^UTILITY(U,$J,358.3,33761,1,3,0)
 ;;=3^36245
 ;;^UTILITY(U,$J,358.3,33762,0)
 ;;=96523^^153^1701^2^^^^1
 ;;^UTILITY(U,$J,358.3,33762,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33762,1,2,0)
 ;;=2^Irrig Drug Delivery Device
 ;;^UTILITY(U,$J,358.3,33762,1,3,0)
 ;;=3^96523
 ;;^UTILITY(U,$J,358.3,33763,0)
 ;;=Z49.31^^154^1702^1
 ;;^UTILITY(U,$J,358.3,33763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33763,1,3,0)
 ;;=3^Adequacy Testing for Hemodialysis
 ;;^UTILITY(U,$J,358.3,33763,1,4,0)
 ;;=4^Z49.31
 ;;^UTILITY(U,$J,358.3,33763,2)
 ;;=^5063058
 ;;^UTILITY(U,$J,358.3,33764,0)
 ;;=N18.6^^154^1702^3
 ;;^UTILITY(U,$J,358.3,33764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33764,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,33764,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,33764,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,33765,0)
 ;;=Z99.2^^154^1702^2
 ;;^UTILITY(U,$J,358.3,33765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33765,1,3,0)
 ;;=3^Dependence on Renal Dialysis
 ;;^UTILITY(U,$J,358.3,33765,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,33765,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,33766,0)
 ;;=Z91.15^^154^1702^4
 ;;^UTILITY(U,$J,358.3,33766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33766,1,3,0)
 ;;=3^Patient's Noncompliance w/ Renal Dialysis
 ;;^UTILITY(U,$J,358.3,33766,1,4,0)
 ;;=4^Z91.15
 ;;^UTILITY(U,$J,358.3,33766,2)
 ;;=^5063617
 ;;^UTILITY(U,$J,358.3,33767,0)
 ;;=Z49.32^^154^1703^1
 ;;^UTILITY(U,$J,358.3,33767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33767,1,3,0)
 ;;=3^Adequacy Testing for Peritoneal Dialysis
 ;;^UTILITY(U,$J,358.3,33767,1,4,0)
 ;;=4^Z49.32
 ;;^UTILITY(U,$J,358.3,33767,2)
 ;;=^5063059
 ;;^UTILITY(U,$J,358.3,33768,0)
 ;;=N18.6^^154^1703^2
 ;;^UTILITY(U,$J,358.3,33768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33768,1,3,0)
 ;;=3^ESRD
